Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Etmar Bulk

Showing results (11-20 of 30) with videos related to

Pageof 3
Sort By:
Scientific Reports|September 16, 2021
K<sub>Ca</sub> channel blockers increase effectiveness of the EGF receptor TK inhibitor erlotinib in non-small cell lung cancer cells (A549)Felix Glaser, Petra Hundehege, Etmar Bulk, et al.
Cell Death Discovery|January 4, 2024
Targeting K<sub>Ca</sub>3.1 channels to overcome erlotinib resistance in non-small cell lung cancer cellsLuca Matteo Todesca, Matthias Gerke, Emma Etmar Bulk, et al.
RSC Advances|April 28, 2022
Synthesis and biological evaluation of PET tracers designed for imaging of calcium activated potassium channel 3.1 (K<sub>Ca</sub>3.1) channels <i>in vivo</i>Kathrin Brömmel, Christian Paul Konken, Frederik Börgel, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|October 18, 2021
Impact of the Nuclear Envelope on Malignant Transformation, Motility, and Survival of Lung Cancer CellsSílvio Terra Stefanello, Isabelle Luchtefeld, Ivan Liashkovich, et al.
Archiv Der Pharmazie|September 26, 2022
Imaging of the calcium activated potassium channel 3.1 (K<sub>Ca</sub> 3.1) in vivo using a senicapoc-derived positron emission tomography tracerChristian P Konken, Kathrin Heßling, Insa Thale, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 8, 2010
The EPHB6 receptor tyrosine kinase is a metastasis suppressor that is frequently silenced by promoter DNA hypermethylation in non-small cell lung cancerJun Yu, Etmar Bulk, Ping Ji, et al.
Asian Journal of Andrology|October 31, 2007
Analysis of the genetic interactions between Cyclin A1, Atm and p53 during spermatogenesisNicole Baumer, Marie-Luise Sandstede, Sven Diederichs, et al.
Cancer Research|March 15, 2008
Adjuvant therapy with small hairpin RNA interference prevents non-small cell lung cancer metastasis development in miceEtmar Bulk, Antje Hascher, Ruediger Liersch, et al.
Cancers|September 5, 2020
pH-Channeling in Cancer: How pH-Dependence of Cation Channels Shapes Cancer PathophysiologyZoltán Pethő, Karolina Najder, Tiago Carvalho, et al.
Plos One|December 11, 2012
Mutations of the EPHB6 receptor tyrosine kinase induce a pro-metastatic phenotype in non-small cell lung cancerEtmar Bulk, Jun Yu, Antje Hascher, et al.
Pageof 3

Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
Scientific Reports|September 16, 2021
K<sub>Ca</sub> channel blockers increase effectiveness of the EGF receptor TK inhibitor erlotinib in non-small cell lung cancer cells (A549)Felix Glaser, Petra Hundehege, Etmar Bulk, et al.
Cell Death Discovery|January 4, 2024
Targeting K<sub>Ca</sub>3.1 channels to overcome erlotinib resistance in non-small cell lung cancer cellsLuca Matteo Todesca, Matthias Gerke, Emma Etmar Bulk, et al.
RSC Advances|April 28, 2022
Synthesis and biological evaluation of PET tracers designed for imaging of calcium activated potassium channel 3.1 (K<sub>Ca</sub>3.1) channels <i>in vivo</i>Kathrin Brömmel, Christian Paul Konken, Frederik Börgel, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|October 18, 2021
Impact of the Nuclear Envelope on Malignant Transformation, Motility, and Survival of Lung Cancer CellsSílvio Terra Stefanello, Isabelle Luchtefeld, Ivan Liashkovich, et al.
Archiv Der Pharmazie|September 26, 2022
Imaging of the calcium activated potassium channel 3.1 (K<sub>Ca</sub> 3.1) in vivo using a senicapoc-derived positron emission tomography tracerChristian P Konken, Kathrin Heßling, Insa Thale, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 8, 2010
The EPHB6 receptor tyrosine kinase is a metastasis suppressor that is frequently silenced by promoter DNA hypermethylation in non-small cell lung cancerJun Yu, Etmar Bulk, Ping Ji, et al.
Asian Journal of Andrology|October 31, 2007
Analysis of the genetic interactions between Cyclin A1, Atm and p53 during spermatogenesisNicole Baumer, Marie-Luise Sandstede, Sven Diederichs, et al.
Cancer Research|March 15, 2008
Adjuvant therapy with small hairpin RNA interference prevents non-small cell lung cancer metastasis development in miceEtmar Bulk, Antje Hascher, Ruediger Liersch, et al.
Cancers|September 5, 2020
pH-Channeling in Cancer: How pH-Dependence of Cation Channels Shapes Cancer PathophysiologyZoltán Pethő, Karolina Najder, Tiago Carvalho, et al.
Plos One|December 11, 2012
Mutations of the EPHB6 receptor tyrosine kinase induce a pro-metastatic phenotype in non-small cell lung cancerEtmar Bulk, Jun Yu, Antje Hascher, et al.
Pageof 3